Barely Significant
← all excerpts

PSMA-targeted therapy for non-prostate cancers.

Front Oncol · 2023 · PMC10461313 · PMID 37645427

Europe PMCDOI
1
hedged sentence
—
closest p
—
boldest claim

The sentences

may be significantno p-value reported
Even if there is lower absorbed tumor dose due to lower and more heterogeneous PSMA expression, there may be significant treatment response in comparison with currently available treatment options for these malignancies.

also in 7,717 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.